Key features and details | |
Cat. No. | MABL-1430 |
Name | Anti-DR4 mAbs |
Clone No. | AFD- mAY4 |
From | Recombinant Antibody |
Isotype | Engineer antibody |
Application | SPR, WB, ELISA |
Species Reactivity | Human |
Basic Information | |
Specificity | mAY4 was shown to bind DR4 by ELISA (Sung et al, 2009). These experiments also showed that mAY4 did not react with other homologous death receptors, including DR5, decoy receptor (DcR) 1, DcR2, FAS receptor, and mTR (a mouse ortholog of human DR4 and DR5). SPR showed an affinity of 7.1 nM for interaction with DR4. mAY4 bound to a different epitope on DR4 than the physiological ligand TRAIL. DR4 is a pro-apoptotic receptor expressed on all cells. It represents a promising target for anti-cancer therapeutic agents. |
Alternative Name | CD261; Death receptor 4; Tumor necrosis factor receptor superfamily member 10A; TNF-related apoptosis-inducing ligand receptor 1; TRAIL receptor 1; TRAILR1; TRAIL-R1; TRAILR 1; TNFRSF10A; APO2 |
UniProt | O00220 |
Immunogen | mAb mAY4 was generated by immunising BALB/c mice with the ECD (residues 1-215) of human DR4. Splenocytes were obtained from immunised mice and fused with murine Sp2/O myeloma cells. mAY4 was cloned by RT-PCR and reformatted as an scFv. |
Application Notes | mAY4 was shown to bind DR4, but not other related homologs, using ELISAs and SPR (Sung et al, 2009). The mAb and scFv-reformatted version were also used in cell viability assays for assessment of tumouricidal activity. More recently, the mAY4 CDRs were humanised and expressed as an scFv-reformatted antibody fragment (Lee et al, 2010), although the humanised version had a 10-fold lower affinity for DR4. |
Antibody First Published | Sung et al. A novel agonistic antibody to human death receptor 4 induces apoptotic cell death in various tumor cells without cytotoxicity in hepatocytes. Mol Cancer Ther. 2009 Aug;8(8):2276-85. PMID:19638452 |
Note on publication | Describes the generation of mAY4, a murine antibody against human DR4. The mAb, and a scFv-reformatted version,were shown to promote DR4-mediated apoptotic activity and prevent tumour growth of human NSCLC tumours established in mice. |
COA Information (For reference only, actual COA shall prevail) | |
Size | 100 μg Purified antibody. |
Concentration | 1 mg/ml. |
Purification | Protein A affinity purified |
Buffer | PBS with 0.02% Proclin 300. |
Concentration | 1 mg/ml. |
Storage Recommendation | Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C. |